Cardiac Monitoring & Cardiac Rhythm Management Market

1. Cardiac Monitoring & Cardiac Rhythm Management Market Overview – Key Futuristic Trends and Opportunities 2025 The cardiac monitoring & cardiac rhythm management market is expected to be worth $XX billion by 2025. The market is largely driven by factors such as rising incidence of cardiovascular disorders along with technological advancements in cardiac monitoring & cardiac rhythm management devices. According to a report published by American Heart Association in 2017, around 92.1 million American adults are living with some or other type of cardiovascular disease. The estimated number of new heart attacks in U.S. is 580,000 with 210,000 incidences of recurrent attacks. Moreover, increasing geriatric population around the world also contributes substantially to the market growth as older adults are more susceptible to cardiovascular disorders such as stroke, heart failure, congenital heart disease, angina, arrhythmia and myocardial infarction. However, high cost of devices, inadequate insurance coverage and more preference for drugs is expected to slow down growth of the cardiac monitoring and rhythm management market. Product Outlook and Trend Analysis The electrocardiogram (ECG) devices segment held the major share of the cardiac monitoring devices market in 2016 owing to their critical benefits in detecting cardiac infarction, coronary vessel diseases, lack or abundance of certain minerals and their influence on impulse conduction and atrial fibrillation or atrial flutter. Event monitors segment is expected to grow with the fastest growth rate during the forecast period owing to their small size and light weight which makes them convenient to be carried to the patient’s site. The defibrillators segment is expected to hold

2. the largest share of the cardiac rhythm management market during the forecast period owing to large scale adoption of defibrillators around the world along with rising incidence of sudden heart attacks (SCA). Get Free Sample of this Report@: https://www.crystalmarketresearch.com/report- sample/HC0696 Product Outlook and Trend Analysis The electrocardiogram (ECG) devices segment held the major share of the cardiac monitoring devices market in 2016 owing to their critical benefits in detecting cardiac infarction, coronary vessel diseases, lack or abundance of certain minerals and their influence on impulse conduction and atrial fibrillation or atrial flutter. Event monitors segment is expected to grow with the fastest growth rate during the forecast period owing to their small size and light weight which makes them convenient to be carried to the patient’s site. The defibrillators segment is expected to hold the largest share of the cardiac rhythm management market during the forecast period owing to large scale adoption of defibrillators around the world along with rising incidence of sudden heart attacks (SCA). End User Outlook and Trend Analysis Hospitals and clinics segment accounted for the majority share of the overall market in 2016 due to the large scale adoption of cardiac monitoring & cardiac rhythm management devices in hospital settings to treat patients suffering from acute and chronic cardiovascular diseases. Ambulatory surgical centers segment is expected to witness fastest growth during the forecast period due to the advent of advanced devices which enable cost effective cardiac monitoring and management as compared to hospital based treatment. Competitive Insights The major players operating in the global cardiac monitoring & cardiac rhythm management market emphasize on product development in order to introduce advanced products in accordance with the changing needs and demands of the market. For instance, in May 2017, Abbott Laboratories announced the CE Mark and first use of its new Confirm Rx Insertable

3. Cardiac Monitor (ICM). It is the world’s first ICM that is compatible with a smartphone which will help physicians in detecting cardiac arrhythmias including atrial fibrillation. Some of the key players operating in the cardiac monitoring & cardiac rhythm management market are Abiomed Berlin Heart GmbH BIOTRONIK SE & Co. KG Boston Scientific Corporation Koninklijke Philips N.V. Cardiac Science Corporation General Electric Company LivaNova PLC, Medtronic plc Nihon Kohden Corporation ReliantHeart Inc. Schiller AG St. Jude Medical, LLC. Get complete access of the Report @ https://www.crystalmarketresearch.com/report/cardiac-monitoring-cardiac-rhythm- management-market Market Opportunities The key opportunity for the players operating in cardiac monitoring & cardiac rhythm management market lies in the development of technologically advanced products which deliver enhanced value to the patients suffering from cardiovascular diseases. Also, miniaturization of products has been a growing trend in the market which largely improves the convenience of use of cardiac monitoring and rhythm management devices. With increasing disposable income in the emerging markets with prevalence of unmet medical needs, market players can largely benefit by expanding distribution to such markets and secure competitive advantage. Table of Contents 1.Introduction

4. 1.1.Report Description 1.2.Research Methodology 2.Executive Summary 2.1.Key Highlights 3.Market Overview 3.1.Introduction 3.1.1. Market Definition 3.1.2. Market Segmentation 3.2.Market Share Analysis 3.3.Market Dynamics 3.3.1. Drivers 3.3.1.1.Increasing Incidence of Cardiovascular Diseases Globally 3.3.1.2.Increasing Geriatric Population Worldwide 3.3.1.3.Technological Advancements in Cardiac Monitoring & Cardiac Rhythm Management Devices 3.3.1.4.Increasing Patient Awareness towards Cardiovascular Diseases 3.3.2. Restraints 3.3.2.1.High Cost of Devices 3.3.2.2.Inadequate Insurance Coverage 3.3.2.3.More Preference towards Drugs by Patients 3.3.3. Opportunities 3.3.3.1.Emerging Markets to Offer Lucrative Growth Opportunities 3.4.Industry Trends Inquiry before Buying @ https://www.crystalmarketresearch.com/send-an- enquiry/HC0696 About Crystal Market Research

5. Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy. Contact Us: 304 South Jones Blvd, Suite 1896, Las Vegas NV 89107, United States Toll Free: + 1-888-213-4282 Email: sales@crystalmarketresearch.com Website: www.crystalmarketresearch.com